Cash Flow

  Year Ending Dec 2020 (Update) Year Ending Dec 2019 (Update) Year Ending Dec 2018 (Update) Year Ending Dec 2017 (Update)
Net Income/Starting Line 323.17 295.78 296.53 257.29
Depreciation – Supplemental 24.51 22.10 22.03
Depreciation/Depletion 24.51 22.10 22.03
Deferred Taxes 1.28 8.29 -10.74
Unusual Items -0.59 0.03 0.12
Equity in Net Earnings (Loss) -10.26 -9.28 -3.89
Other Non-Cash Items 44.06 25.25 21.07 17.71
Non-Cash Items 44.06 14.41 11.82 13.94
Accounts Receivable 8.46 -28.83 -1.68
Inventories -15.53 -78.95 -73.40
Accounts Payable 12.73 -57.40 99.96
Other Assets & Liabilities, Net 167.15 -5.87 -2.99 -0.89
Changes in Working Capital 167.15 -0.21 -168.17 23.99
Cash from Operating Activities 534.38 335.77 170.56 306.52
Purchase of Fixed Assets -16.34 -17.81 -17.15 -17.88
Capital Expenditures -16.34 -17.81 -17.15 -17.88
Acquisition of Business -- -59.67 -5.63
Sale of Fixed Assets 1.38 0.23 0.17
Sale/Maturity of Investment --
Purchase of Investments -4.94 -3.76 -63.60
Other Investing Cash Flow Items, Total -- -63.23 -9.16 -63.43
Cash from Investing Activities -16.34 -81.04 -26.31 -81.31
Other Financing Cash Flow -27.08 -55.21 -49.86 -77.47
Financing Cash Flow Items -27.08 -55.21 -49.86 -77.47
Cash Dividends Paid - Common -265.71 -241.41 -209.22 -164.15
Total Cash Dividends Paid -265.71 -241.41 -209.22 -164.15
Sale/Issuance of Common 13.34 6.59 5.24
Common Stock, Net 13.34 6.59 252.99
Issuance (Retirement) of Stock, Net 13.34 6.59 252.99
Long Term Debt Issued 20.50 135.20
Long Term Debt Reduction -- -0.79
Long Term Debt, Net -155.70 19.26 112.88 -213.51
Issuance (Retirement) of Debt, Net -155.70 19.26 112.88 -213.51
Cash from Financing Activities -448.49 -264.02 -139.60 -202.15
Foreign Exchange Effects 2.07 0.85 -2.25 1.42
Net Change in Cash 71.61 -8.44 2.40 24.49
Net Cash - Beginning Balance 74.45 82.89 80.50 56.01
Net Cash - Ending Balance 146.07 74.45 82.89 80.50
Cash Interest Paid 4.34 3.07 5.77
Cash Taxes Paid 70.10 115.30 48.06

In millions of USD (except for per share items)

Copyright Refinitiv